Fusion Antibodies plc (AIM:FAB)
London
· Delayed Price · Currency is GBP · Price in GBX 6.32
+0.22 (3.52%)
May 13, 2025, 1:21 PM GMT+1
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 6.91 million as of May 13, 2025. Its market cap has increased by 104.18% in one year.
Market Cap
6.91M
Enterprise Value
6.51M
Revenue
1.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.32
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 6.91M, a decrease of -74.66%. That is a compound annual growth rate of -16.93%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.79B |
| GSK plc | 55.98B |
| Haleon | 36.67B |
| Smith & Nephew | 9.35B |
| ConvaTec Group | 5.26B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 1.95B |
| Genus | 1.39B |